Home › Funds › Venrock Adviser, LLC › COGT

Venrock Adviser, LLC position in COGT

COGENT BIOSCIENCES INC · Health Care

Venrock Adviser, LLC reported holding 1,642,166 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$63.6M, representing 1.93% of its reported portfolio and ranking #10 among its reported holdings. Venrock Adviser, LLC has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.64M sh
Reported value held$63.55M
Portfolio Weight1.93%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's COGT position evolved

Venrock Adviser, LLC first disclosed a stake in COGT in Q3 2023 at 4,684,167 shares (US$45.7M). The position peaked in Q1 2026 at 2,000,000 shares, worth US$77.0M. Across 12 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,642,166 shares valued at US$63.6M — a reduction of -357,834 shares quarter over quarter.. Notable position changes include a 50% trim in Q4 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.68M $45.67M New
Q4 2023 4.68M $27.54M Hold
Q1 2024 5.13M $34.47M Add
Q2 2024 5.68M $47.92M Add
Q3 2024 5.68M $61.39M Hold
Q4 2024 5.68M $44.34M Hold
Q1 2025 5.68M $34.05M Hold
Q2 2025 4.76M $34.14M Reduce
Q3 2025 4.00M $57.44M Reduce
Q4 2025 2.00M $71.04M Reduce
Q1 2026 2.00M $76.98M Hold
Q2 2026 1.64M $63.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Venrock Adviser, LLC held COGT?

Venrock Adviser, LLC has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Venrock Adviser, LLC's current position in COGT?

As of Q2 2026, Venrock Adviser, LLC holds 1.64M shares of COGT (COGENT BIOSCIENCES INC), valued at $63.55M, representing 1.93% of its reported portfolio and ranking #10.

Has Venrock Adviser, LLC been buying or selling COGT?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC reduced its position in COGT. The position peaked in Q1 2026 at 2.00M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.